CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $56,516,510 | $101,463,600 | $122,265,280 | $136,068,040 |
| - Cash | $8,586,000 | $8,196,000 | $12,945,000 | $9,408,000 |
| + Debt | $82,920,000 | $79,385,000 | $70,732,000 | $75,999,000 |
| Enterprise Value | $130,850,510 | $172,652,600 | $180,052,280 | $202,659,040 |
| Revenue | $372,809,000 | $357,776,000 | $322,467,000 | $292,111,000 |
| % Growth | 4.2% | 10.9% | 10.4% | – |
| Gross Profit | $51,401,000 | $54,431,000 | $54,502,000 | $52,120,000 |
| % Margin | 13.8% | 15.2% | 16.9% | 17.8% |
| EBITDA | $13,683,000 | $18,197,000 | $12,347,000 | $17,526,000 |
| % Margin | 3.7% | 5.1% | 3.8% | 6% |
| Net Income | $4,614,000 | $8,344,000 | $4,311,000 | $8,001,000 |
| % Margin | 1.2% | 2.3% | 1.3% | 2.7% |
| EPS Diluted | 3.66 | 6.47 | 3.26 | 5.95 |
| % Growth | -43.4% | 98.5% | -45.2% | – |
| Operating Cash Flow | $9,107,000 | $13,426,000 | $16,177,000 | $18,265,000 |
| Capital Expenditures | -$2,781,000 | -$3,031,000 | -$2,727,000 | -$2,520,000 |
| Free Cash Flow | $6,326,000 | $10,395,000 | $13,450,000 | $15,745,000 |